Join Mailing List   |   Print Page   |   Contact Us   |   Sign In   |   Join
JTH Volume 13 - 2015
Share |

Journal of Thrombosis and Haemostasis

Volume 13 (2015)

Kaatz, S, Ahmad, D, Spyropoulos, A. C, Schulman, S. and for the SSC Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13:2119-2126.

Thachil, J,  Falanga A, Levi M, Liebman, H and DiNisio M. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply. J Thromb Haemost 2015; 13:1352-1353.

Bodo, I, Eikenboom, J, Montgomery, R, Patzke, J, Schneppenheim, R, Di Paola, J. and on behalf of the SSC Subcommittee on von Willebrand Factor. Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13:1345-1350.

Hubbard A. R, Heath, A. B, Kremer Hovinga, J. A and for the Subcommittee on von Willebrand Factor. Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH. J Thromb Haemost 2015; 13:1151-1153.

Barnes, G. D,  Ageno, W, Ansell J, Kaatz S, and for the Subcommittee on the Control of Anticoagulation. Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13:1154-1156.

Di Nisio M, Lee A. Y. Y, Carrier M, Liebman H. A, Khorana A. A, and for the Subcommittee on Hemostasis and Malignancy. Diagnosis and treatment of the incidental venous thrombosis in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13:880-883. 

Dimichele D. M, Lacroix-Desmazes S, Peyvandi F, Srivastava A,  Rosendaal F.R. and for the Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders. Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH. J. Thromb Haemost 2015; 13: 876-879. 

Bakchoul T, Chong B. H, Bougie D, Aster R. and for the Subcommittee on Platelet Immunology. Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13:872-875. 

Arnold D. M, Curtis B. R, Bakchoul T. and for the Subcommittee on Platelet Immunology. Recommendations for standardization of laboratroy testing for drug induced thrombocytopenia: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13: 676-8.

Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. Management of cancer-associate disseminate intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13:671-675. 

Male C., P. Monagle, A. K. C. Chan, G. Young, and for the Subcommittee on Pediatric/Neonatal Hemostasis and Thrombosis. Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH. J Throm Haemost 2015; 13: 481-484.

Rajpurkar M, Sharathkumar A, Williams S, Lau K, Ling S. C, Chan A.. K, and for the Subcommittee on Pediatric/Neonatal Hemostasis and Thrombosis. Recommendations for the assessment of non-extremity venous thromboembolism outcomes: communication from the SSC of the ISTH. J Throm Haemost 2015; 13: 477-480.

Gresele P. and for the Subcommittee on Platelet Physiology. Diagnosis of inherited platelet function disorders: Guidance  from the SSC of the ISTH. J Thromb Haemost 2015; 13: 314-322. 

Newall, F., S. Jones, M. Bauman, A. Bruce, M. P. Massicotte, P. Monagle and for the Subcommittee on Perinatal and Paediatric Haemostasis. Recommendations for the development of a dedicated pediatric anticoagulation service: communication from the SSC of the ISTH. J Throm Haemost 2015; 13: 155-159.

 

 

 

Membership Management Software Powered by YourMembership.com®  ::  Legal